XPO1 and mantle cell lymphoma: In mantle cell lymphoma (MCL), higher XPO1 expression at diagnosis is associated with a poorer prognosis, with a median overall survival of 3.2 years in the low expression XPO1 cases vs 1.9 years in the high expression XPO1 cases [18].